• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

ACA Medicaid expansion cut disparities in cancer care for minorities, poor

Bioengineer by Bioengineer
September 26, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Duke Health

DURHAM, N.C. — States that fully expanded their Medicaid programs under the Affordable Care Act cut their rates of uninsured cancer patients by more than half between 2011 and 2014. Black patients and those living in the highest poverty areas saw the greatest benefit from Medicaid expansion, according to a Duke Cancer Institute analysis.

Rates of uninsured cancer patients in states without Medicaid expansion also declined, but in these states, improvements appeared to primarily benefit white patients and residents of low-poverty areas, with a portion transitioning to non-Medicaid health insurance.

There were no improvements in uninsured rates for black patients and residents of high-poverty areas in states without Medicaid expansion. In fact, patients in these groups appeared to be losing insurance coverage, although this finding was not statistically significant, according to lead study author Fumiko Chino, M.D., a radiation oncologist at Duke.

The data will be presented Sept. 26 as part of the press program at an annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego. The analysis is based on the records of more than 197,000 people ages 18 to 64 in a National Cancer Institute database who received radiation for a cancer diagnosis between 2011 and 2014.

"The debate over health care reform is ongoing," Chino said. "Our findings indicate that Medicaid expansion was effective at decreasing disparities and improving access to care for cancer patients receiving radiation, but some disparities still exist. In states without Medicaid expansion, the rates of uninsured patients went down, but those who benefited were white patients living in higher-income areas, for whom it might have been possible to purchase plans through the health care exchange."

According to the study data, states with expanded Medicaid programs cut the rate of uninsured cancer patients receiving radiation from 4.4 percent to 2.1 percent. At the same time, the proportion of Medicaid recipients rose from 15.2 to 18 percent.

Inversely, in states without Medicaid expansion, Medicaid enrollment dropped from 15.9 to 14.9 percent for cancer patients receiving radiation, while the portion of these patients having non-Medicaid insurance coverage grew from 75.7 to 77.1 percent.

"This study is part of a developing body of research to quantify healthcare delivery changes under the ACA," Chino said. "We now are assessing if these insurance changes translate to differences in patient survival."

###

In addition to Chino, study authors include Gita Suneja, Haley Moss, S. Yousuf Zafar, Laura Havrilesky and Junzo Chino.

Media Contact

Samiha Khanna
[email protected]
919-419-5069
@DukeHealth

http://www.dukehealthnews.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Next-Gen Oncology: Precision Genomics Meets Immuno-Engineering

September 20, 2025

Prostate-Specific Antigen Testing: Past, Present, Future

September 20, 2025

Bisabolol: Natural Anticancer Agent with Therapeutic Promise

September 20, 2025

VDAC1 Analysis and Natural Inhibitors in Gynecological Tumors

September 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Next-Gen Oncology: Precision Genomics Meets Immuno-Engineering

Prostate-Specific Antigen Testing: Past, Present, Future

Bisabolol: Natural Anticancer Agent with Therapeutic Promise

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.